Zealand Pharma Statistics

Total Valuation

Zealand Pharma has a market cap or net worth of GBP 5.91 billion. The enterprise value is 4.91 billion.

Market Cap	5.91B
Enterprise Value	4.91B

Important Dates

The next estimated earnings date is Thursday, February 20, 2025.

Earnings Date	Feb 20, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+15.69%
Shares Change (QoQ)	+12.72%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	60.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	5.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-41.80
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-62.29

Financial Position

The company has a current ratio of 35.49, with a Debt / Equity ratio of 0.04.

Current Ratio	35.49
Quick Ratio	35.20
Debt / Equity	0.04
Debt / EBITDA	n/a
Debt / FCF	-0.55
Interest Coverage	-38.58

Financial Efficiency

Return on equity (ROE) is -19.67% and return on invested capital (ROIC) is -12.44%.

Return on Equity (ROE)	-19.67%
Return on Assets (ROA)	-11.81%
Return on Capital (ROIC)	-12.44%
Revenue Per Employee	28,785
Profits Per Employee	-394,135
Employee Count	253
Asset Turnover	0.01
Inventory Turnover	122.31

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +61.23% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+61.23%
50-Day Moving Average	749.15
200-Day Moving Average	774.73
Relative Strength Index (RSI)	44.77
Average Volume (20 Days)	8,590

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Zealand Pharma had revenue of GBP 8.58 million and -117.45 million in losses. Loss per share was -1.85.

Revenue	8.58M
Gross Profit	-70.00M
Operating Income	-124.47M
Pretax Income	-117.97M
Net Income	-117.45M
EBITDA	-123.41M
EBIT	-124.47M
Loss Per Share	-1.85

Full Income Statement

Balance Sheet

The company has 946.39 million in cash and 43.46 million in debt, giving a net cash position of 983.63 million.

Cash & Cash Equivalents	946.39M
Total Debt	43.46M
Net Cash	983.63M
Net Cash Per Share	n/a
Equity (Book Value)	991.26M
Book Value Per Share	14.03
Working Capital	945.47M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -77.09 million and capital expenditures -1.74 million, giving a free cash flow of -78.83 million.

Operating Cash Flow	-77.09M
Capital Expenditures	-1.74M
Free Cash Flow	-78.83M
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,451.03%
Pretax Margin	-1,375.25%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Zealand Pharma does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-15.69%
Shareholder Yield	-15.69%
Earnings Yield	-1.99%
FCF Yield	-1.33%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Zealand Pharma has an Altman Z-Score of 31.29.

Altman Z-Score	31.29
Piotroski F-Score	n/a